- Zacks•2 days ago
Ligand Pharmaceuticals Incorporated (LGND) reported fourth-quarter 2016 earnings of 50 cents per share (including the impact of stock-based compensation expense), down 11.1% from the year-ago figure.
- Thomson Reuters StreetEvents•3 days ago
Q4 2016 Ligand Pharmaceuticals Inc Earnings Call
- Associated Press•3 days ago
On a per-share basis, the San Diego-based company said it had a loss of 15 cents. Earnings, adjusted for non-recurring costs and stock option expense, were 74 cents per share. The drugmaker posted revenue ...
LGND : Summary for Ligand Pharmaceuticals Incorpor - Yahoo Finance
Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||95.08 - 100.48|
|52 Week Range||87.50 - 139.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||287.62|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|